Precision Proteomics Inc. (PPI) is a biotechnology firm that develops and commercializes a unique proteomics platform for fundamental, preclinical, and clinical research, as well as next-generation precision medicine research. PPI's unique technology, which includes the SH2 Supberbinder (SH2S), enables cutting-edge proteomics to meet the demands of our customers and colleagues in therapeutics research, development, and clinical use.

https://precisionproteomics.ca/